ONC BeOne Medicines Ltd.
Healthcare$304.78+0.00%OpenMarket Cap: $32.57B
As of 2026-05-26
Institutional Ownership Summary
Investors Holding
351
13F Shares
50,258,963
Ownership %
45.6%
New Positions
109
Increased Positions
224
Closed Positions
41
Reduced Positions
72
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| VanEck Biotech ETF | 40,622 | 3.23% | |
| Tema Oncology ETF | 11,361 | 2.01% | |
| iShares Biotechnology ETF | 529,143 | 1.93% | |
| 1,171,171 | 1.37% | ||
| 1,171,171 | 1.37% | ||
| 2,320,922 | 0.93% | ||
| 2,320,922 | 0.93% | ||
| Capital Group Global Equity ETF | 47,680 | 0.62% | |
| Capital Group International Equity ETF | 31,568 | 0.48% | |
| Capital Group New Geography Equity ETF | 16,034 | 0.26% | |
| Fidelity Contrafund | 822,038 | 0.16% | |
| Dimensional - Emerging Core Equity Market ETF | 12,186 | 0.04% | |
| Invesco RAFI Emerging Markets ETF | 25,700 | 0.03% | |
| Avantis Emerging Markets Equity ETF | 11,267 | 0.02% | |
| First Trust NYSE Arca Biotechnology Index Fund | 241,840 | 0.00% |